The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 329.50
Bid: 328.00
Ask: 329.50
Change: 0.00 (0.00%)
Spread: 1.50 (0.457%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 329.50
PIN Live PriceLast checked at -
Pantheon International is an Investment Trust

To maximise capital growth by investing in a diversified portfolio of private equity funds and occasionally directly in private companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Enlarged credit facility with maturity extension

2 Aug 2022 10:34

RNS Number : 6151U
Pantheon International PLC
02 August 2022
 

2 August 2022

For immediate release

The information contained in this announcement is restricted and is not for publication, release or distribution in the United States of America, Canada, Australia (other than to persons who are both wholesale clients and professional or sophisticated investors in Australia), Japan, the Republic of South Africa or any other jurisdiction where its release, publication or distribution is or may be unlawful.

Pantheon International Plc

("PIP" or the "Company")

 

Enlarged credit facility with maturity extension

 

The Company announces that it has agreed a new £500m multi-tranche, multi-currency revolving credit facility agreement (the "Loan Facility"), which replaces the existing £300m credit facility agreement that was due to expire in May 2024. The new £500m Loan Facility, which is secured by certain assets of the Company, is due to expire in July 2027 with an ongoing option to extend, by agreement, the maturity date by another year at a time. The Loan Facility has been arranged by three lenders comprising a new partner in the lending syndicate, Credit Suisse AG, London Branch, and two existing lenders, Lloyds Bank Corporate Markets plc and State Street Bank International GmbH. The Loan Facility has been denominated as to US$ 512.9m and 89.2m to more closely match the principal currencies in which PIP's undrawn commitments are denominated.

 

PIP will pay a blended commitment fee of 95 basis points per annum on the wholly undrawn Loan Facility. Depending on the utilisation of the Loan Facility, the margin payable would be equivalent to the relevant benchmark rate plus 2.350% to 2.575%. The Loan is subject to market standard loan to value and liquidity covenants.

 

PIP's portfolio, which has a weighted average age of 4.9 years as at 31 May 2022, is strongly cash generative. The Company expects to continue to finance its new investments and meet its unfunded commitments, amounting to £761m as at 30 June 2022 (at prevailing exchange rates), principally from cash generated from the Company's portfolio. As at 30 June 2022, PIP had net available cash of £194m. Therefore, based on current exchange rates, PIP's total liquid financial resources, taking into account the terms of the new Loan Facility and net available cash as at 30 June 2022 are equivalent to £694m.

 

Commenting on the Loan Facility, Sir Laurie Magnus CBE, Chair of PIP, said: "The Board is delighted to have secured this enlarged and extended Loan Facility on competitive terms in the current environment. This is testimony to the quality of PIP's portfolio of private equity investments and provides PIP with greater flexibility in managing its asset base."

 

This announcement has been determined to contain inside information for the purposes of the market abuse regulation (EU) No.596/2014.

 

Ends

 

LEI: 2138001B3CE5S5PEE928

 

For more information, please visit PIP's website at www.piplc.com or contact:

 

Pantheon

Helen Steers / Vicki Bradley

020 3356 1800

 

Follow us on LinkedIn: https://www.linkedin.com/company/pantheon-international-plc

 

 

NOTES

 

PIP

PIP is a listed FTSE 250 private equity investment trust, overseen by an independent Board of Directors and managed by Pantheon, one of the leading private equity investment managers globally. PIP offers investors a liquid, differentiated entry point to the excellent growth potential of global private equity, with access to the primary, secondary and co-investment opportunities of some of the best managers in the world. The Company has a track record of outperformance and manages risk through diversification and rigorous selection based on Pantheon's extensive experience and international platform.

 

Pantheon

PIP is managed and advised by Pantheon, a leading global private equity, infrastructure & real assets and private debt investor with 40 years' experience sourcing and executing private market investment opportunities on behalf of clients. Pantheon has $84.6 billion in AUM^^^^ (as at 31 December 2021) and employs approximately 417 staff including 121 investment professionals across offices in London, San Francisco, New York, Chicago, Hong Kong, Seoul, Bogotá, Tokyo, Dublin and Berlin.

 

^^^^This figure includes assets subject to discretionary or non-discretionary management, advice or those limited to a reporting function.

 

 

Important Information

A copy of this announcement will be available on the Company's website at www.piplc.com. Neither the content of the Company's website, nor the content on any website accessible from hyperlinks on its website for any other website, is incorporated into, or forms part of, this announcement nor, unless previously published by means of a recognised information service, should any such content be relied upon in reaching a decision as to whether or not to acquire, continue to hold, or dispose of, securities in the Company.

Sir Laurie Magnus CBE

Chairman, Pantheon International Plc

Beaufort House, 51 New North Road, Exeter, Devon, EX4 4EP

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDKLLBBLVLXBBX
Date   Source Headline
1st Feb 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSMonthly Performance Update
26th Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSPrivate Placement Debt Issue
11th Jan 20247:00 amRNSKepler Trust Intelligence: New Research
5th Jan 20247:00 amRNSMonthly Performance Update
2nd Jan 202411:32 amRNSTotal Voting Rights
20th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSMonthly Performance Update
1st Nov 202310:39 amRNSTotal Voting Rights
30th Oct 202312:53 pmRNSHolding(s) in Company
23rd Oct 202311:22 amRNSHolding(s) in Company
20th Oct 20237:00 amRNSMonthly Performance Update
19th Oct 20231:12 pmRNSResult of AGM
19th Oct 202310:00 amRNSCOMPLETION OF TENDER OFFER AND TOTAL VOTING RIGHTS
19th Oct 20237:00 amRNSRefinanced Credit Facility
18th Oct 20238:18 amRNSResult of Tender Offer
28th Sep 202312:06 pmRNSInvestor Presentation
25th Sep 20237:00 amRNSTender Offer
22nd Sep 20237:00 amRNSMonthly Performance Update
19th Sep 202312:41 pmRNSHolding(s) in Company
1st Sep 202312:16 pmRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSMonthly Performance Update
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
14th Aug 20237:00 amRNSTransaction in Own Shares
11th Aug 20234:00 pmRNSQuotedData's Weekly News & Interview
11th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20235:22 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSTransaction in Own Shares
9th Aug 202310:51 amRNSDirector/PDMR Shareholding
8th Aug 20232:54 pmRNSDirector/PDMR Shareholding
8th Aug 202311:59 amRNSDirector/PDMR Shareholding
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20235:22 pmRNSTransaction in Own Shares
4th Aug 20234:32 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.